- This event has passed.
HKAPI Regulatory Training Workshop Series – Seminar 3
March 11, 2022 @ 2:00 pm - 4:30 pm
HKAPI Regulatory Training Workshop Series- Seminar 3
Date: 11 March 2022 (Fri)
Time: 2:00 pm – 4:30 pm
RSVP: Please contact the HKAPI Office
Fee: To be confirmed
Content
| Time | Topic | Speaker |
| 2:00 pm – 2:20 pm | Global Trend of e-labeling: and case sharing | Dr. Sara Ellmark
Executive Regulatory Science Director Astrazeneca |
| 2:20 pm – 2:30pm | Q&A | Ms. Susanna Yim (Moderator)
Associate Director Regulatory Affairs at Janssen Pharmaceutical Companies of Johnson & Johnson / Sub-team Lead of HKAPI Regulatory Affairs |
| 2:30 pm – 3:05 pm | Updates on CORP Registration | Mr. Albert Chung
Pharmacist Drug Office Department of Health |
| 3:05 pm – 3:20 pm | Q&A | Ms. Susanna Yim (Moderator)
Associate Director Regulatory Affairs at Janssen Pharmaceutical Companies of Johnson & Johnson / Sub-team Lead of HKAPI Regulatory Affairs |
| 3:20 pm – 3:25 pm | Break | |
| 3:25 pm – 4:30 pm | Workshop on CORP Registration:
Exercises to enhance submission standard and learn from best practice |
Education Sub-team of HKAPI Regulatory Affairs |
About the Speaker
Dr. Sara ELLMARK
Executive Regulatory Science Director, AstraZeneca Sweden
PhD, Molecular Biology, Gothenburg University, Sweden
Sara has 15+ years’ experience in pharmaceutical development in various roles across medical communications, regulatory affairs and global labelling.
Her current role is Executive Regulatory Science Director in AstraZeneca, and previously she led AstraZeneca’s Global Labelling Group. Sara has also been actively engaged in e-labelling related activities, both within AstraZeneca and as an active member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) ePI working group, as well as the Inter-Association Task Force (IATF) for e-labelling.
